Comparison of Vestibular and Dual-Task Rehabilitation in Parkinson's Disease
Parkinson's disease (PD) is a long-term condition that affects movement, balance, and thinking abilities. It can cause tremor, stiffness, slow movements, and difficulty maintaining balance. In addition to these physical problems, many people with PD also experience difficulties with memory, attention, and other cognitive functions. The balance system in the inner ear (vestibular system) helps maintain posture and orientation, but this system may not work properly in people with PD. This study aims to compare two different types of exercise programs to improve movement, balance, and cognitive abilities in individuals with PD. One program focuses on exercises that stimulate the balance system (vestibular rehabilitation), while the other combines thinking and movement activities at the same time (dual-task training). Thirty-six people with PD will take part in the study. Participants will be randomly assigned to one of three groups: vestibular exercise group, dual-task exercise group, or control group. Exercises will be done under the supervision of a physiotherapist twice a week for eight weeks. Each session will last about 40 minutes and include activities that are safe, structured, and personalized. Before and after the 8-week program, participants will complete simple tests that measure their memory, attention, walking ability, balance, and daily activity level. The results will show whether these exercise approaches can help improve both body and brain functions. The findings of this study are expected to help physiotherapists design more effective and personalized rehabilitation programs for people with Parkinson's disease, leading to better balance, safer movement, and improved quality of life.
Study identifier: NCT07277205. Status: RECRUITING. Phase: NA.
Eligibility
Criteria: Inclusion Criteria: * Individuals aged between 40 and 75 years * Diagnosed with idiopathic Parkinson's disease (IPD) * Stable medication regimen within the past one month * Hoehn and Yahr stage I-III * A score of at least 22 on the Montreal Cognitive Assessment (MoCA) * Participants evaluated during the "on" phase of their medication cycle * No hearing and/or visual impairments Exclusion Criteria: * Presence of any neurological, cardiovascular, or orthopedic disorder that may interfere with walking * Diagnosis of any other neurological disease (e.g., dementia, cerebrovascular disease) * Patients with deep brain stimulation (DBS) implants * Presence of vascular pathologies in the lower extremities
- Minimum age: 40 Years
- Maximum age: 75 Years
Participating locations
- Marmara University, Istanbul, Maltepe
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.